Yue Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yue Wang has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Fang Wang
Department of Oral and Maxillofacial Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, China; School of Stomatology, Binzhou Medical University, Yantai, China
2 shared publicationsGuoyi Xing
Department of Oral and Maxillofacial Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, China; School of Stomatology, Binzhou Medical University, Yantai, China; Wuhan Dongxihu District People's Hospital
2 shared publicationsHonghai Fu
Department of Oral and Maxillofacial Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, China; School of Stomatology, Binzhou Medical University, Yantai, China
2 shared publicationsShuhan Wang
School of Stomatology, Qilu Medical University, Zibo, China
2 shared publicationsWenhao Ren
Department of Oral and Maxillofacial Reconstruction/Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China; School of Stomatology, Qingdao University, Qingdao 266003, China; Key Lab of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
2 shared publicationsChunxia Liu
Department of Oral and Maxillofacial Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, China
1 shared publication
Latest Publications
- Open Access
- 18 June 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Two-year follow-up outcomes of neoadjuvant therapy in oral squamous cell carcinoma: an exploratory systematic review and meta-analysis
Neoadjuvant therapy has been increasingly explored as a treatment strategy for oral squamous cell carcinoma (OSCC) and may be associated with favorable pat
- 18 June 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Open AccessTwo-year follow-up outcomes of neoadjuvant therapy in oral squamous cell carcinoma: an exploratory systematic review and meta-analysis
Neoadjuvant therapy has been increasingly explored as a treatment strategy for oral squamous cell carcinoma (OSCC) and may be associated with favorable pat
- Open Access
- 8 October 2025
- Published by Elsevier in International Dental Journal
- Vol. 75 (6) , 103947
Head and Neck Cancer Incidence, Mortality, and Disability-Adjusted Life Years From 1990 to 2021-A Systematic Analysis for the Global Burden of Disease Study
- 8 October 2025
- Published by Elsevier in International Dental Journal
- Vol. 75 (6) , 103947
Open AccessHead and Neck Cancer Incidence, Mortality, and Disability-Adjusted Life Years From 1990 to 2021-A Systematic Analysis for the Global Burden of Disease Study
- Open Access
- 30 June 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (10) , 7440-7442
Clinical challenges and advances in HPV-related oropharyngeal squamous cell carcinoma
An abstract is unavailable. This article is available as a PDF only.
- 30 June 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (10) , 7440-7442
Open AccessClinical challenges and advances in HPV-related oropharyngeal squamous cell carcinoma
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 16 December 2023
- Published by Elsevier in International Dental Journal
- Vol. 74 (3) , 543-552
p16 and p53 can Serve as Prognostic Markers for Head and Neck Squamous Cell Carcinoma
- 16 December 2023
- Published by Elsevier in International Dental Journal
- Vol. 74 (3) , 543-552
Open Accessp16 and p53 can Serve as Prognostic Markers for Head and Neck Squamous Cell Carcinoma
- 29 June 2022
- Published by Wiley in Oral Diseases
- Vol. 29 (8) , 3152-3156
Competing endogenous RNA analysis reveals the regulatory potency of CKAP5 in HPV+ HNSCC
- 29 June 2022
- Published by Wiley in Oral Diseases
- Vol. 29 (8) , 3152-3156
Competing endogenous RNA analysis reveals the regulatory potency of CKAP5 in HPV+ HNSCC